Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

NCT05149456 | Unknown

• 1 other identifier: 8373
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The cardiovascular risk of women has been the subject of particular interest in recent years, in the world, in particular under the impetus of Cardiology companies, with more and more work focusing on the specificities of these diseases in women as well as differences in terms of management and prognosis with a literature mainly based on American data and which focuses particularly on ischemic heart disease. The expected results are to have a prevalence of PAOD in an Alsatian cohort, most of the data we currently have from American data, with analysis of the impact of specific and non-specific risk factors in this cohort and their weight in PAOD.

Conditions

PAOD - Peripheral Arterial Occlusive Disease

Keywords

Peripheral Arterial Occlusive Disease; PAOD; Cardiovascular risk factors; Myocardial infarction

Outcome Measures

Primary Outcomes (1)

• Study of the prevalence of peripheral artery occlusive disease (PAOD)

  Files analysed retrospectively from January 01, 2021 to Jun 30, 2021 will be examined]

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult woman hospitalized in an Intensive Cardiology Unit (ICU) at the HUS for a type 1 myocardial infarction confirmed according to the criteria of the fourth universal definition of the ESC between 01/01/2021 to 30/06/2021 inclusive

You may qualify if:

• Adult woman (≥18 years old)
• Patient hospitalized in an Intensive Cardiology Unit (ICU) at the HUS for a type 1 myocardial infarction confirmed according to the criteria of the fourth universal definition of the ESC between 01/01/2021 to 30/06/2021 inclusive
• Patient who did not express her opposition to the reuse of her data for scientific research purposes.

You may not qualify if:

• Patient who expressed her opposition to participating in the study
• Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, MMS \<20/30…)
• Non-type 1 or unconfirmed myocardial infarction
• Unstable or refractory shock state at the time of the echodoppler examination
• Complication of the coronary angiography approach, in the case of femoral approach only, requiring surgical management.
• Patient under curatorship, guardianship or judicial safeguard.

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service des Maladies VASC-HTA-Pharmacologie Clinique - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Peripheral Arterial Occlusive Disease 1; Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis

Study Officials

• Dominique STEPHAN, MD, PhD

  Service des Maladies VASC-HTA-Pharmacologie Clinique - Hôpitaux Universitaires de Strasbourg

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Dominique STEPHAN, MD, PhD

CONTACT

33 3 69 55 09 52; dominique.stephan@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

said.chayer@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 24, 2021
• First Posted: December 8, 2021
• Study Start: August 15, 2021
• Primary Completion: August 1, 2022
• Study Completion: August 31, 2022
• Last Updated: December 8, 2021

Record last verified: 2021-11

Locations

FR (1)